Jackson Square Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.6M Buy
18,872
+309
+2% +$316K 3.15% 7
2026
Q1
$17.1M Buy
18,563
+126
+0.7% +$128K 3.58% 6
2025
Q4
$19.8M Buy
18,437
+3,875
+27% +$3.71M 3.92% 7
2025
Q3
$11.1M Sell
14,562
-5,749
-28% -$4.28M 2.42% 9
2025
Q2
$15.8M Buy
20,311
+1,149
+6% +$893K 3.52% 5
2025
Q1
$15.8M Sell
19,162
-38
-0.2% -$31.6K 5.15% 3
2024
Q4
$14.8M Sell
19,200
-3,677
-16% -$3.04M 3.57% 6
2024
Q3
$20.3M Sell
22,877
-1,318
-5% -$1.18M 5.03% 4
2024
Q2
$21.9M Buy
24,195
+112
+0.5% +$89.6K 5.39% 4
2024
Q1
$18.7M Buy
24,083
+35
+0.1% +$24.9K 4.82% 4
2023
Q4
$14M Sell
24,048
-101
-0.4% -$59K 4.51% 3
2023
Q3
$13M Buy
24,149
+486
+2% +$250K 5.21% 3
2023
Q2
$11.1M Sell
23,663
-2,095
-8% -$879K 4.46% 3
2023
Q1
$8.85M Buy
25,758
+2,049
+9% +$691K 3.96% 4
2022
Q4
$8.67M Sell
23,709
-675
-3% -$239K 4.08% 2
2022
Q3
$7.88M Sell
24,384
-645
-3% -$204K 3.85% 4
2022
Q2
$8.12M Buy
25,029
+548
+2% +$164K 3.43% 4
2022
Q1
$7.01M Buy
24,481
+1,813
+8% +$467K 2.19% 9
2021
Q4
$6.26M Buy
22,668
+492
+2% +$125K 1.8% 13
2021
Q3
$5.12M Sell
22,176
-36
-0.2% -$8.88K 1.67% 18
2021
Q2
$5.1M Sell
22,212
-276
-1% -$55.4K 1.64% 21
2021
Q1
$4.2M Buy
22,488
+4,340
+24% +$849K 1.6% 21
2020
Q4
$3.06M Sell
18,148
-2,524
-12% -$377K 1.18% 32
2020
Q3
$3.06M Buy
20,672
+932
+5% +$144K 1.35% 28
2020
Q2
$3.24M Buy
19,740
+8,234
+72% +$1.26M 1.64% 24
2020
Q1
$1.6M Buy
11,506
+1,586
+16% +$218K 1.24% 31
2019
Q4
$1.3M Buy
+9,920
New +$1.15M 0.75% 48

Other funds holding LLY

Jackson Square Capital's LLY Position: Q2 2026 in Review

Jackson Square Capital increased its Eli Lilly (LLY) stake by 1.7% in Q2 2026, buying an estimated $316K and bringing the position to 18,872 shares worth $22.6M. The position accounts for 3.15% of the portfolio, ranked #7.

Jackson Square Capital first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 1,021 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Jackson Square Capital held 18,872 shares of Eli Lilly worth $22.6M as of Q2 2026.
  • Jackson Square Capital bought 309 Eli Lilly shares in Q2 2026, an estimated $316K.
  • Eli Lilly made up 3.15% of Jackson Square Capital's portfolio in Q2 2026, its #7 holding.
  • Jackson Square Capital first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 1,021 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Jackson Square Capital's 13F filing for Q2 2026, filed 21 Jul 2026.